- IHH Healthcare (SGX:Q0F)'s 4Q23 core profit came off by 28% q-o-q to MYR266m (below expectations) amid a seasonally weaker quarter due to the holiday and festive seasons.
- We continue to like IHH Healthcare given its reputable regional footprint across key regions, its organic expansion target (+33% bed capacity by 2028), and resilient demand for healthcare services.
- - Read this at SGinvestors.io -
Results overview.
- IHH Healthcare's FY23 full-year core earnings came in at 91% and 79% of our and Street’s estimates, which we deem as below expectations, no thanks to increases in staff and utilities costs, and a weakening TRY.
- - Read this at SGinvestors.io -
- In 2023, IHH Healthcare’s operational beds grew to 12,307 (2022: 11,881 beds). Group bed occupancy rate (BOR) contracted slightly (69% vs 2022’s 70%).
Segmental breakdown.
- Read more at SGinvestors.io.
Oong Chun Sung RHB Securities Research | https://www.rhbgroup.com/ 2024-03-01
Read also RHB's most recent report:
2024-05-30 IHH Healthcare - Earnings Supercharged By Strong Operating Stats; BUY.
Previous report by RHB:
2024-03-05 IHH Healthcare - Thriving In All Regions; Keep BUY.
Price targets by other brokers at IHH Healthcare Target Prices.
Listing of research reports at IHH Healthcare Analyst Reports.
Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividends & Corporate Actions,
IHH Healthcare News Articles
